GenesysCapital_Logo
  • About
  • Team
  • Portfolio
  • News
  • LP Login
LP Login

Driving Breakthroughs in Healthcare, One Bold Idea at a Time

Featured

11 June 2025

Genesys Capital is closing its largest fund to date – Genesys Ventures IV LP

Latest

World’s First Wearable Doppler Ultrasound Patch Expands to East Coast to Enhance Patient Safety at The Mount Sinai Hospital

17 June 2025

Palisade Bio Reports Positive Phase 1a Results for PALI-2108, a First-in-Class Terminal Ileum and Colon-Targeted PDE4 B/D Inhibitor for Fibrostenotic Crohn’s Disease and Ulcerative Colitis

27 May 2025

Initial Perioperative Data from CAPTAIN Randomized Trial Demonstrate MRI-Guided TULSA Provides Statistically Significant Improvement of Post-Operative Experience Vs. Robotic Radical Prostatectomy

29 April 2025

All Articles

18 February 2025

Feldan Therapeutics Accelerates Growth with Strategic Investment from Linearis Ventures

Read More
22 January 2025

Feldan Announces the Appointment of Eric Carter, PH.D., M.D., to its Board of Directors

Read More
16 January 2025

New Study Explores a Unique Approach to Sepsis Care: Nursing-Led Ultrasound-Guided Emergency Response Teams

Read More
10 January 2025

Veralox Therapeutics Expands Its Pipeline with the Exclusive Option to Acquire Nudge Therapeutics

Read More
06 December 2024

Profound Medical Announces Pricing of US$35 Million Underwritten Public Offering of Common Shares

Read More
02 December 2024

Profound Medical and Siemens Healthineers to Offer a Complete Solution for MRI-guided Prostate Therapy

Read More
Previous
Load More
2 / 4
About
Team
Portfolio
News
Contact
GenesysCapital_Logo
123 Front Street West, Suite 1503
Toronto ON M5J 2M2
info@genesyscapital.com
Follow us on LinkedIn
Privacy Policy
© 2025 Genesys Capital. All rights reserved.